Clinical consensus conference: survey on Gram-positive bloodstream infections with a focus on Staphylococcus aureus
- PMID: 19374582
- DOI: 10.1086/598185
Clinical consensus conference: survey on Gram-positive bloodstream infections with a focus on Staphylococcus aureus
Abstract
The increased incidence over the past decade of bloodstream infections (BSIs) caused by gram-positive bacteria, particularly methicillin-resistant Staphylococcus aureus, highlights the critical need for a consistent approach to therapy. However, there is currently no international consensus on the diagnosis and management of gram-positive BSIs. The Clinical Consensus Conference on Gram-Positive Bloodstream Infections was convened as a session at the 9th International Symposium on Modern Concepts in Endocarditis and Cardiovascular Infections held in 2007. Participants discussed various aspects of the practical treatment of patients who present with gram-positive BSI, including therapeutic options for patients with BSIs of undefined origin, the selection of appropriate empirical therapy, and treatment of complicated and uncomplicated BSIs. The opinions of participants about these key issues are reflected in this article.
Similar articles
-
Staphylococcus aureus bloodstream infections: definitions and treatment.Clin Infect Dis. 2009 May 15;48 Suppl 4:S254-9. doi: 10.1086/598186. Clin Infect Dis. 2009. PMID: 19374581 Review.
-
Management of gram-positive coccal bacteremia and hemodialysis.Am J Kidney Dis. 2011 Apr;57(4):624-40. doi: 10.1053/j.ajkd.2010.12.013. Epub 2011 Feb 18. Am J Kidney Dis. 2011. PMID: 21333430
-
Patients at risk of complications of Staphylococcus aureus bloodstream infection.Clin Infect Dis. 2009 May 15;48 Suppl 4:S246-53. doi: 10.1086/598187. Clin Infect Dis. 2009. PMID: 19374580
-
New antibiotic agents for bloodstream infections.Int J Antimicrob Agents. 2008 Nov;32 Suppl 1:S60-5. doi: 10.1016/j.ijantimicag.2008.06.003. Epub 2008 Aug 23. Int J Antimicrob Agents. 2008. PMID: 18723329 Review.
-
Pyomyositis as a nontropical disease.Curr Clin Top Infect Dis. 1997;17:37-50. Curr Clin Top Infect Dis. 1997. PMID: 9189660 Review. No abstract available.
Cited by
-
Cefazolin versus Nafcillin for Methicillin-Sensitive Staphylococcus aureus Bloodstream Infection in a California Tertiary Medical Center.Antimicrob Agents Chemother. 2016 Jul 22;60(8):4684-9. doi: 10.1128/AAC.00243-16. Print 2016 Aug. Antimicrob Agents Chemother. 2016. PMID: 27216053 Free PMC article.
-
Once-Daily Treatments for Methicillin-Susceptible Staphylococcus aureus Bacteremia: Are They Good Enough?Curr Infect Dis Rep. 2017 Sep 23;19(11):43. doi: 10.1007/s11908-017-0599-0. Curr Infect Dis Rep. 2017. PMID: 28942574 Review.
-
Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia (ARREST): study protocol for a randomised controlled trial.Trials. 2012 Dec 18;13:241. doi: 10.1186/1745-6215-13-241. Trials. 2012. PMID: 23249501 Free PMC article. Clinical Trial.
-
The complex pathogenesis of bacteremia: from antimicrobial clearance mechanisms to the genetic background of the host.Virulence. 2014 Jan 1;5(1):57-65. doi: 10.4161/viru.26514. Epub 2013 Sep 25. Virulence. 2014. PMID: 24067507 Free PMC article. Review.
-
Prevalence of infective endocarditis in patients with Staphylococcus aureus bacteraemia: the value of screening with echocardiography.Eur J Echocardiogr. 2011 Jun;12(6):414-20. doi: 10.1093/ejechocard/jer023. Eur J Echocardiogr. 2011. PMID: 21685200 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous